JPRN-jRCT2031220005招募中3 期
An Open-label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults with Chronic Immune Thrombocytopenia
Shimizu Yasuko0 个研究点目标入组 19 人开始时间: 2022年4月8日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 19
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Men and women >_18 years of age.
- •-Subject has a confirmed diagnosis of chronic ITP (>_12 months duration) and has had an insufficient response to a previous ITP treatment, in the opinion of the Investigator.
- •-Subject has an average of 2 platelet counts <30x10^9/L (no single count can be >35x10^9/L). The 2 samples must be obtained >_48 hours and <_2 weeks apart.
排除标准
- •'-Subjects with known secondary immune thrombocytopenia (e.g., with known Helicobacter pylori-induced ITP, subjects infected with known human immunodeficiency virus [HIV] or hepatitis C virus [HCV] or subjects with known systemic lupus erythematosus).
- •-Subjects with known inherited thrombocytopenia (e.g., MYH-9 disorders) or hereditary thrombophilic disorders (e.g., Factor V Leiden, antithrombin III deficiency).
研究者
相似试验
未知
3 期
An Open-label Study to Evaluate the Efficacy and Safety of ABT-450/r/ABT-267 Co-administered With Ribavirin for 12 or 16 Weeks in Treatment-Naive and Treatment-Experienced Japanese Adults With Genotype 2 Chronic HCV Infection With and Without Compensated Cirrhosis (GIFT-II)JPRN-jRCT2080222382AbbVie GK
已完成
不适用
A clinical trial to assess the Efficacy and Safety of LPOTC001-11 versus Colgate Plax in dental plaques and gingivitisCTRI/2012/02/002460aila Pharmaceuticals Pvt Ltd40
进行中（未招募）
4 期
To Evaluate the Safety of an Ayurvedic Water Based Juice in Healthy VolunteersCTRI/2024/04/065700Sesa Care Private Limited
进行中（未招募）
1 期
An Efficacy and Safety Study of Alirocumab in Children and Adolescents with Homozygous Familial HypercholesterolemiaMedDRA version: 20.0 Level: PT Classification code 10020603 Term: Hypercholesterolaemia System Organ Class: 10027433 - Metabolism and nutrition disordersHomozygous Familial HypercholesterolemiaEUCTR2017-002297-39-FRSanofi-Aventis Recherche & Développement50
进行中（未招募）
1 期
An Efficacy and Safety Study of Alirocumab in Children and Adolescents with Homozygous Familial HypercholesterolemiaMedDRA version: 20.0Level: PTClassification code 10020603Term: HypercholesterolaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersHomozygous Familial HypercholesterolemiaEUCTR2017-002297-39-SISanofi-Aventis Recherche & Développement50